Catalyst Wire Dossier Catalyst Wire Dossier

PSC-MSC-Exo eye drops

pluripotent stem cell-derived mesenchymal stem cell exosome · Second Affiliated Hospital, School of Medicine, Zhejiang University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PSC-MSC-Exo eye drops, covering 2023-02-22 to 2023-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm [Phase 1, Phase 2]

See pricing